Analysis of Chemical Structures and Therapeutic Activity of Agents for HIV, TB, and HBV (ChemDB)

The National Institutes of Health is forecasting a contract opportunity for the analysis of chemical structures and therapeutic activity of agents targeting HIV, tuberculosis, and hepatitis B virus, as part of the ChemDB initiative. This effort will involve in-depth evaluation of molecular compounds to understand their structure-activity relationships, efficacy, and potential for clinical development against these persistent infectious diseases. The work is expected to support drug discovery and development by compiling and interpreting structural and biological data to identify promising candidates and optimize therapeutic potential. The contract falls under NAICS code 541714, which corresponds to research and development in the physical, engineering, and life sciences. The program point of contact is Mohamed Nasr, and the contracting officer is Patrick Finn, both affiliated with the NIH. Although the solicitation number and set-aside details are not yet available, the opportunity is expected to be issued in the future, with performance likely to occur at locations determined by the contractor. Interested parties should monitor the official HUD OSDBU portal for subsequent formal solicitations and submission guidelines.